Patents for A61K 49 - Preparations for testing in vivo (35,376) |
---|
04/30/1997 | CN1148812A Liposomes |
04/29/1997 | US5624909 Derivatives of triterpenoid acids as inhibitors of cell-adhesion molecules ELAM-1 (e-selectin) and LECAM-1 (l-selectin) |
04/29/1997 | US5624685 High polymer gel and vascular lesion embolizing material comprising the same |
04/29/1997 | US5624662 Liposoluble heterocyclic compounds useful as magnetic resonance imaging agents |
04/29/1997 | US5624661 Hypoosmotic compositions comprising a polymer and a complexed contrast agent for MRI |
04/29/1997 | US5624660 Stress response imaging by detection of decreased protein synthesis |
04/24/1997 | WO1997014796A1 Monoclonal antibody br110 and uses thereof |
04/24/1997 | WO1997014679A2 Method of detecting cyclooxygenase-2 |
04/24/1997 | WO1997014445A1 Dopamine and serotonin transporter ligands and imaging agents |
04/24/1997 | WO1997014444A1 Methods of screening for compounds which modulate insect behavior |
04/24/1997 | WO1997014443A1 Magnetically labeled chemoattractants as targeted contrast agents in the nmr imaging of living tissues |
04/24/1997 | WO1996040282A3 Nucleation and activation techniques for use in ultrasound imaging |
04/24/1997 | CA2234633A1 Method of detecting cyclooxygenase-2 |
04/23/1997 | EP0769145A1 N-heteroaromatic ion and iminium ion substituted cyanine dyes for use as fluorescence labels |
04/23/1997 | EP0768898A1 Cascade-polymer complexes and methods of producing the same |
04/23/1997 | EP0593624B1 Improvements in or relating to contrast agents |
04/23/1997 | EP0586524B1 Improvements in or relating to contrast agents |
04/23/1997 | CN1148384A Chelant compounds |
04/23/1997 | CN1148377A Omega-hydrofluoroalkyle ethers, precursor carboxylic acid and derivatives thereof, and their prepn. and application |
04/23/1997 | CN1148338A Increasing fetal hemoglobin level using carboxylic esters |
04/22/1997 | US5622946 Radiation sensitization using texaphyrins |
04/22/1997 | US5622938 Sugar base surfactant for nanocrystals |
04/22/1997 | US5622688 Contrast agents for magnetic resonance imaging |
04/22/1997 | US5622687 Calixarene conjugates useful as MRI and CT diagnostic imaging agents |
04/22/1997 | US5622686 Diagnosis and treatment of viral effects using magnetic metal transferrin particles |
04/22/1997 | US5622685 Tumor active or tumor diagnostic substances which exhibit preferred accumulation in tumor; reduced side effects |
04/22/1997 | CA2031265C Methods of detecting collagen degradation in vivo |
04/17/1997 | WO1997013503A1 Synthesis of drug nanoparticles by spray drying |
04/17/1997 | WO1997013490A2 Contrasting agents for near infrared diagnosis containing colloidal systems loaded with polymethine dyes |
04/17/1997 | WO1997002050A3 Solid oral diagnostic test meal and methods of use thereof |
04/17/1997 | DE19539409A1 Kontrastmittel für die Nahinfrarot-Diagnostik Contrast agents for near infrared diagnosis |
04/17/1997 | CA2233995A1 Contrasting agents for near infrared diagnosis containing colloidal systems loaded with polymethine dyes |
04/16/1997 | EP0767779A1 Alpha-(cycloalkyl, aryl and aralkyl)substituted polyiodinated aroyloxy compounds |
04/16/1997 | EP0767778A1 1-PHENOXY-3-N-ALKYLAMINOPROPAN-2-OL HALOGEN DERIVATIVES USEFUL AS MYOCARDIAL $g(b) ADRENERGIC RECEPTOR MARKERS AND AS $g(b)-BLOCKING AGENTS |
04/16/1997 | EP0767679A1 Low viscosity chelating polymers |
04/16/1997 | EP0767621A1 Implantable capsule for enhancing cell electric signals |
04/16/1997 | EP0454782B1 Cancer related haptoglobin (hpr) |
04/15/1997 | US5620884 Modified polyether |
04/15/1997 | US5620677 Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract |
04/10/1997 | WO1997012898A1 Novel platelet activation protein |
04/10/1997 | WO1997012624A1 Novel peptides |
04/10/1997 | WO1997012551A2 Improvements in or relating to ultrasound imaging |
04/10/1997 | WO1997012513A1 Dopamine transporter knockout mice |
04/10/1997 | WO1997003697A3 Fluorogenic substrates for diagnosis and photodynamic treatment of tumours |
04/10/1997 | CA2233994A1 Novel platelet activation protein |
04/10/1997 | CA2233272A1 Novel peptides |
04/09/1997 | EP0766968A1 Diagnostic imaging agent |
04/09/1997 | EP0766698A1 Isolated nucleic acid encoding retinol dehydrogenase |
04/09/1997 | EP0766663A1 2,4,6-triiodo-5-substituted-amino-isophthalate esters useful as x-ray contrast agents for medical diagnostic imaging |
04/09/1997 | EP0680464B1 Derivated dtpa complexes, pharmaceuticals containing these compounds, their use as nmr- and radiographic contrasting agents and process for producing the same |
04/09/1997 | EP0671955A4 Mutagenesis testing using transgenic non-human animals carrying test dna sequences. |
04/09/1997 | EP0588875B1 Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same |
04/09/1997 | EP0568574B1 Method of preparation of a pyrogen-free fructane which is readily soluble in water, and an agent containing such a fructane for the examination of kidney function |
04/09/1997 | CN1147206A X-ray contrast compositions contg. pharmaceutically acceptable clays |
04/08/1997 | US5618977 Polyiodinated compounds, process of preparation and contrast agent containing them |
04/08/1997 | US5618528 Biologically compatible linear block copolymers of polyalkylene oxide and peptide units |
04/08/1997 | US5618514 Diagnostic and contrast agent |
04/08/1997 | US5617872 Hypersensitive constriction velocity method for diagnosing Alzheimer's disease in a living human |
04/08/1997 | US5617860 Method and system for producing polarized 129 Xe gas |
04/07/1997 | CA2160052A1 Diagnostic imaging agent |
04/03/1997 | WO1997011721A1 Method to identify therapeutically active compounds |
04/03/1997 | WO1997011686A1 Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions |
04/03/1997 | WO1997011683A2 Stabilised phospholipid compositions |
04/03/1997 | CA2233135A1 Stabilised phospholipid compositions |
04/02/1997 | EP0765867A1 Substituted benzoyl guanidines, process for their preparation, their use as antiarrhythmics or diagnostic agent as well as pharmaceuticals containing them |
04/02/1997 | EP0765343A1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6 |
04/02/1997 | CN1146726A Block copolymers |
04/01/1997 | US5616798 Poly-iodinated compounds, process for their preparation, contrast medium containing them |
04/01/1997 | US5616342 Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof |
04/01/1997 | US5616312 Thiol ligands and complexes for X-ray imaging |
03/28/1997 | CA2186580A1 Substituted benzoylguanidines, a process for their preparation, their use as medicament or diagnostic agent, and medicament comprising them |
03/27/1997 | WO1997010854A1 (radio) labelled biotin derivatives |
03/27/1997 | WO1997004756A3 Methacrylate backbone surfactants in nanoparticulate formulations |
03/27/1997 | WO1997002051A3 Cascade polymer complexes |
03/27/1997 | WO1997000088A3 Rotavirus enterotoxin nsp4 and methods of using same |
03/27/1997 | WO1996040273A3 Conjugates of ferrites and oligonucleotides, which bond specifically to certain target structures |
03/27/1997 | WO1996029974A3 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
03/27/1997 | CA2232411A1 (radio) labelled biotin derivatives |
03/26/1997 | EP0739337A4 Functionalized macrocyclic ligands for imaging applications |
03/26/1997 | EP0533775B1 Labeled compounds for use in a diagnostic breath test |
03/26/1997 | CN1146197A Cyclic triamine chelating agents |
03/26/1997 | CN1146159A X-ray contrast compositions containing cellulose derivatives |
03/25/1997 | US5614652 Cytotoxic, palladium disposed within an iron oxide matrix |
03/25/1997 | US5614638 Nonionic radiographic contrast agents |
03/25/1997 | US5614170 Contrast agents of diethylenetriaminepentaacetic acid chelate compounds |
03/25/1997 | US5614169 Contrast agents, consisting of galactose particles and an amphilic carboxylic acid |
03/25/1997 | US5614168 Multinuclear complexes for X-ray imaging |
03/25/1997 | US5614167 Polyvinylpyrrolidone film |
03/25/1997 | US5613494 Ultrasonic contrast agent, microparticles containing a gas |
03/25/1997 | CA2067178C Solid tumor treatment method and composition |
03/25/1997 | CA2050479C Cd3 specific recombinant antibody |
03/25/1997 | CA1339015C Macrocyclic chelates and methods of use thereof |
03/25/1997 | CA1339014C Antibodies to a4 amyloid peptide |
03/20/1997 | WO1997010281A1 Selectively functionalizable desdendrimers |
03/20/1997 | DE19620154A1 In-vivo diagnosis e.g. of tumours using e.g. near IR |
03/20/1997 | CA2231840A1 Selectively functionalizable desdendrimers |
03/19/1997 | EP0762899A1 Stabilized homogenous suspensions as computed tomography contrast agents |
03/19/1997 | EP0762849A1 A diagnostic method for establishing food intolerance/allergy, and an instrument for use when carrying out the method |
03/19/1997 | EP0626974B1 Mitogen-free substance, its preparation and its use |
03/19/1997 | EP0566590B1 Particulates |